Boule Diagnostics
Egetis attracts a bid and agrees to sell its priority review voucher, Lytix meets its endpoint in melanoma and Novo raises its outlook – the Nordic Pulse | 2026:45
Genmab clears a pivotal hurdle, AstraZeneca dominates ESMO and Bonesupport surges on Q3 – the Nordic Pulse | 2026:43– the Nordic Pulse | 2026:43
Zealand wins in obesity, Genmab hits first-line DLBCL and Oncopeptides crosses the blood-brain barrier – the Nordic Pulse | 2026:41
AstraZeneca’s hat-trick, a broad sell-off and Alzinova funds its Alzheimer’s push – the Nordic Pulse | 2026:37
Simonetta Tumbiolo tar över som tillförordnad vd för Boule Diagnostics
Boule Diagnostics vd lämnar bolaget
Nyhetssvepet torsdag 8 maj
S2Medical
Nyhetssvepet måndag 28 april
Magle PharmaCept
Nyhetssvepet torsdag 24 april
BioArctic
Nyhetssvepet måndag 14 april
Lipum
Nyhetssvepet tisdag 8 april
Xspray Pharma
Nyhetssvepet torsdag 13 mars
Neola Medical
